OraSure Expands HIV Self-Test to Canada Amid Rising Diagnoses
Event summary
- OraSure’s OraQuick™ HIV Self-Test received Health Canada license on February 10, 2026.
- Canada’s first oral HIV self-test detects antibodies for HIV-1 and HIV-2 in 20 minutes.
- 2024 data shows 1,826 new HIV diagnoses in Canada (excluding Québec), with Manitoba and Saskatchewan reporting rates 3-4x the national average.
- St. Michael’s Hospital (Unity Health Toronto) is the exclusive distributor in Canada.
The big picture
OraSure’s expansion into Canada with its OraQuick™ HIV Self-Test aligns with global efforts to democratize HIV testing and reduce stigma. The move is strategically significant given the rising diagnosis rates in certain provinces, particularly Manitoba and Saskatchewan. This launch also underscores the growing trend of decentralized diagnostics, enabling individuals to take control of their health outside traditional clinical settings.
What we're watching
- Market Penetration
- Whether OraSure can effectively reach the estimated 7,000+ undiagnosed individuals in Canada through this self-test.
- Regulatory Dynamics
- How Health Canada’s approval process for diagnostic tools may influence future product launches in the region.
- Competitive Positioning
- The pace at which competitors introduce similar self-testing solutions in Canada and other global markets.
Related topics